Clinical

The AJMC^® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care^® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.

Latest News

Myasthenia Gravis | Image Credit: © lexiconimages-stock.adobe.com

ADAPT SERON Trial Shows Positive Results for Seronegative gMG

By Marco Meglio

August 28th 2025

Efgartigimod shows promise as a groundbreaking treatment for seronegative generalized myasthenia gravis (gMG), addressing a critical unmet need in patient care.

A pragmatic, food-based, low-dose OIT protocol was effective at inducing peanut desensitization after 12 months and was associated with meaningful quality of life improvement. | Image Credit: Angela Schmidt - stock.adobe.com

Peanut Allergy Treatment Improves Quality of Life vs Peanut Avoidance

By Jared Kaltwasser

August 28th 2025

Salpingectomy demonstration | Image Credit: shidlovski - stock.adobe.com

Missed Opportunities for Salpingectomy Highlight Gaps in Ovarian Cancer Prevention

By Brooke McCormick

August 27th 2025

HIV older couple | Image credit: LIGHTFIELD STUDIOS - stock.adobe.com

Long-Term Survivors of HIV Willing to Engage in End-of-Life Research

By Julia Bonavitacola

August 25th 2025

Pink ribbon for breast cancer | Image Credit: © Andrey Popov - stock.adobe.com

Remote Weight Loss Intervention Reduces Body Weight in Women With Breast Cancer

By Sabrina McCrear

August 25th 2025

More News

Backbone Therapy in Newly Diagnosed Multiple Myeloma

June 28th 2019

Watch

How Real-World Data Can Address Problems in MM

June 28th 2019

Watch

$Dosing Strategies in Relapsed-Refractory MM$

Dosing Strategies in Relapsed-Refractory MM

June 28th 2019

Watch

$Initiating Treatment in Relapsed-Refractory MM$

Initiating Treatment in Relapsed-Refractory MM

June 28th 2019

Watch

What Is the Cost of Recurrence in Multiple Myeloma?

June 28th 2019

Watch

Daratumumab in the Treatment Landscape for MM

June 28th 2019

Watch

Clinical Significance of MRD Testing in MM

June 28th 2019

Watch

Practical Implications of the MAIA Study for MM

June 28th 2019

Watch

Considerations for Transplant-Ineligible Patients

June 28th 2019

Watch

NCCN Guidelines for Newly Diagnosed MM

June 28th 2019

Watch

Achieving the Best Outcomes for Patients With MM

June 28th 2019

Watch

Cost Considerations of Multidrug Regimens in MM

June 28th 2019

Watch

Factoring Age Into Frontline Therapy for MM

June 28th 2019

Watch

Individualizing Therapy for Multiple Myeloma Patients

June 28th 2019

Watch

June Halper Outlines the Biggest Management Challenges in Multiple Sclerosis

June 22nd 2019

The biggest clinical challenges that we have in treating multiple sclerosis are 2-fold, explained June Halper, MSN, APN-C, MSCN, FAAN, chief executive officer, Consortium of Multiple Sclerosis Centers.

Watch

Evaluating Use of Bone-Modifying Agents to Treat Skeletal-Related Events in Cancer

Laura Joszt, MA

June 15th 2019

Skeletal-related events are frequent complications in patients with cancers. Two abstracts analyzed the use of bone-modifying agents in patients with newly diagnosed multiple myeloma and breast cancer.

Identifying Biomarkers to Predict Disease Severity, Progression, and Cognitive Impairment in MS

Laura Joszt, MA

June 6th 2019

Two abstracts presented at the 33rd Annual Meeting of the Consortium of Multiple Sclerosis Centers analyzed biomarkers to predict progression, disease severity, and cognitive impairment in multiple sclerosis (MS).